In vitro activity of anidulafungin against Candida albicans biofilms

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 6, 2008, Pages 2242-2243

  Jacobson, Melissa J ^a   Piper, Kerryl E ^a   Nguyen, Gary ^a   Steckelberg, James M ^a   Patel, Robin ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ANIDULAFUNGIN; CASPOFUNGIN; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; FUNGUS ISOLATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIBIOTICS, ANTIFUNGAL; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 44449091941     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00211-08     Document Type: Article

References (9)

1. Bachmann, S. P., K. VandeWalle, G. Ramage, T. F. Patterson, B. L. Wickes, J. R. Graybill, and J. L. Lopez-Ribot. 2002. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 46:3591-3596.
2. Chandra, J., D. M. Kuhn, P. K. Mukherjee, L. L. Hoyer, T. McCormick, and M. A. Ghannoum. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183: 5385-5394.
3. Choi, H. W., J. H. Shin, S. I. Jung, K. H. Park, D. Cho, S. J. Kee, M. G. Shin, S. P. Suh, and D. W. Ryang. 2007. Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals. Antimicrob. Agents Chemother. 51:1520-1523.
4. Clinical and Laboratory Standards Institute. 2002. Method for broth dilution testing of yeasts - second edition: approved standard M27-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Hawser, S. P., and L. J. Douglas. 1994. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Immun. 62:915-921.
6. Katragkou, A., A. Chatzimoschou, M. Simitsopoulou, M. Dalakiouridou, E. Diza-Mataftsi, C. Tsantali, and E. Roilides. 2008. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob. Agents Chemother. 52:357-360.
7. Mermel, L. A., B. M. Farr, R. J. Sherertz, I. I. Raad, N. O'Grady, J. S. Harris, and D. E. Craven. 2001. Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 32:1249-1272.
8. Shuford, J. A., K. E. Piper, J. M. Steckelberg, and R. Patel. 2007. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates. Diagn. Microbiol. Infect. Dis. 57:277-281.
9. Shuford, J. A., M. S. Rouse, K. E. Piper, J. M. Steckelberg, and R. Patel. 2006. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J. Infect. Dis. 194:710-713.